Stada Arzneimittel AG’s “rapid expansion” strategy for its consumer health-focused Branded Products division has begun to bear fruit with the acquisition of a basket of six OTC brands from GlaxoSmithKline PLC for an undisclosed sum.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?